Patient Guide: Hodgkin lymphoma pembrolizumab trials (KEYNOTE-087, KEYNOTE-204, KEYNOTE-0872 eligible entries)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTKEYNOTE-087
Status: ANNOUNCED
Condition: Hodgkin lymphoma
Phase: NA

Loading interactive enrollment tools...

The full interactive experience will load momentarily